-  This bill is not active in this session.
 
     
  •  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

S02677 Summary:

BILL NOS02677A
 
SAME ASSAME AS A00463-A
 
SPONSORBRESLIN
 
COSPNSRHOYLMAN-SIGAL, SKOUFIS
 
MLTSPNSR
 
Amd 4902 & 4903, Ins L; amd 4902 & 4903, Pub Health L
 
Requires written notice of an adverse determination made by a utilization review agent in relation to a step therapy protocol override determination.
Go to top